๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost-Effectiveness of Olanzapine as a First-Line Treatment: A Response to Comment

Book ID
109078590
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
30 KB
Volume
9
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacoeconomic profile of paclitaxel a
Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma : A lifetime cost-effectiveness analysis
โœ Andrea Messori; Michele Cecchi; Paola Becagli; Sabrina Trippoli ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 2 views

medullary recurrence in certain ethnic groups will be the field have read the article. I agree that there is no proof that all-trans retinoic acid (ATRA) therapy confirmed by further observation and analysis of recurrence in the large cooperative group studying APL. predisposes patients to the deve

Mitoxantrone as a first-line treatment o
Mitoxantrone as a first-line treatment of advanced breast cancer
โœ Karl Landys; Stig Borgstrom; Torsten Andersson; Henry Noppa ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 354 KB

Forty-two Women with measurable or evaluable advanced breast cancer who had received neither prior chemotherapy for advanced disease nor any anthracycline-containing regimen as adjuvant were entered in a phase II study of mitoxantrone (Novantrone| dihydroxyanthracenedione). Patients were aged from 3